Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2026-07-04 @ 4:24 PM
Study NCT ID:
NCT00071006
Status:
COMPLETED
Last Update Posted:
2012-06-08
First Post:
2003-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A4061013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None